Naming | 'VitalCare', an AI solution for Predicting Patients' Deterioration
With the meaning of patient health care through AI...Monitor the vital signs in real time To increase the availability and work efficiency of medical staff, and to provide improved medical services to patients AI-specialized company 'AITRICS' that opens a new pathways for healthcare. Over the past three years, the COVID-19 pandemic has further highlighted the shortage of manpower in the domestic health care sector. According to major indicators released by the MOHW in 2022, domestic clinicians and nursing staff were insufficient compared to the OECD average. In fact, among OECD countries, Korea ranks in the lower ranks with 2.5 clinicians and 8.4 nurses per 1,000 population. In a situation where there is a lack of medical staff, the burden of monitoring many patients at the same time is bound to increase. In addition, there was a high demand for the importance of early alarms in various diseases because there was a risk that medical staff would miss patients' vital signs. In October of last year, AITRICS (CEO Kim Kwang-jun, Yoo Jin-kyu, AITRICS), a company specializing in medical artificial intelligence technology, launched AITRCIS-VC (hereinafter referred to as VitalCare). VitalCare is an AI software that monitors the patient's condition in the hospital in real time and predicts the risk of deterioration of the patient's condition at an early stage. VitalCare was created by combining the meanings of “Vital (essential for maintaining life)” and “Care (managing the patient’s health).” To put it simply, it is AITRICS's first medical device product made with the meaning of caring for patients' conditions through AI. As the meaning is melted in the product name, VitalCare predicts patients' deterioration with AI technology by monitoring vital signs such as breathing, pulse, and body temperature in real time. Based on 19 data such as vital signals and blood tests, predict the risk of patient condition deterioration. In addition, a total of 19 comprehensive data, including vital signals collected from electronic medical records (EMR), blood test results and consciousness status, and the patient's age, are used to accurately determine the patient's abnormal symptoms. Medical scores such as the existing assessment tools MEWS, APACHE-2, and SOFA add up the patient's risk score to monitor the current severity. The indications of VitalCare are ▲Predicting the risk of major adverse events in Genaral Ward (Mortality, Unexpected Intensive Care Unit Transfer, CPR) ▲Predicting Sepsis risk in General Ward within 4 hours ▲Predicting Mortality risk in Intensive Care Unit within 6 hours. In particular, Sepsis and Mortality risk is the first and only one in Korea. A company official said, "VitalCare has established an interface tailored to users' convenience as well as excellent clinical performance," adding, "It was designated as the breakthrough device in December last year and was selected as a investigational device exemption approval in January and is currently being actively introduced by various medical institutions."